Completed NA INTERVENTIONAL NCT00457106

A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks

Sponsor: Beth Israel Medical Center

Conditions Major Depression With Panic Attacks Panic Disorder

Updated 5 times since 2017 Last updated: Nov 30, 2010 Started: Jun 30, 2002 Primary completion: Jun 30, 2003 Completion: Jun 30, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00457106, this NA trial focuses on Major Depression With Panic Attacks and Panic Disorder and remains completed. Sponsored by Beth Israel Medical Center, it has been updated 5 times since 2002, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jun 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beth Israel Medical Center

Data source: Beth Israel Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States